{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:43:06Z","timestamp":1769557386992,"version":"3.49.0"},"reference-count":64,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Rosacea is a common skin condition with quite a relevance. It currently affects at least 10% of the European population at some point after the age of 30. It is a chronic disorder that mainly affects the skin on the face and is characterized by outbreaks and remissions. Under normal circumstances, the skin face presents a wide range of commensal organisms, such as Staphylococcus epidermidis or Demodex folliculorum, but dysbiosis of the skin flora plays a relevant role in inflammatory processes and the development of the disease. Metronidazole (MD) is one of the main treatments indicated to reduce redness on the cheeks, nose, chin, or forehead and also to treat flushing, erythema, pimples, and other symptoms due in part to its anti-inflammatory action. On the other hand, clindamycin (CM) is another antibiotic used for rosacea, especially for its action against anaerobic and Gram-positive bacteria. Background\/Objectives: This study aimed to develop an emulgel formulation that includes MD and CM, using excipients with non-comedogenic and non-irritating properties. Methods: The formulation was characterised physiochemically, rheological measurements were made, and short-term stability studies were carried out. In vitro release, permeation studies, toxicity an in vitro inflammation model were evaluated in a HaCaT cell model. To determine the interaction between the antibiotics, the minimum inhibitory concentration was determined separately and together using the broth microdilution method. To determine the formulation\u2019s antimicrobial activity, an agar diffusion method was used. Results: The MD-CM-gel droplet size was measured by laser diffraction and the diameter obtained was less than 2.68 \u00b1 0.18 \u00b5m in 50% of the particles. Suitable results was observed for the short-term stability. Release and permeation data revealed sustained drug release and adequate permeation through human skin. Non-toxicity was detected and the MD showed an anti-inflammatory effect with non-interference of CM. Also, there is no antagonism between the two antibiotics and the MD-CM-gel shows better results when compared to the formulations with the antibiotics separately and to commercial formulations. Conclusions: It is suggested that, following detailed preclinical and clinical studies, MD-CM-gel could be considered as an alternative for treating rosacea.<\/jats:p>","DOI":"10.3390\/pharmaceutics17020168","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T04:59:10Z","timestamp":1737953950000},"page":"168","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Emulgel Containing Metronidazole and Clindamycin for the Treatment of Rosacea"],"prefix":"10.3390","volume":"17","author":[{"given":"Guillermo","family":"De Grau-Bassal","sequence":"first","affiliation":[{"name":"Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farm\u00e0cia i Ci\u00e8ncies de l\u2019Alimentaci\u00f3, Universitat de Barcelona (UB), 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4989-4821","authenticated-orcid":false,"given":"Ana Cristina","family":"Calpena-Campmany","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"},{"name":"Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9906-049X","authenticated-orcid":false,"given":"Marcelle","family":"Silva-Abreu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"},{"name":"Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9238-187X","authenticated-orcid":false,"given":"Joaquim","family":"Su\u00f1er-Carb\u00f3","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"},{"name":"Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-8459","authenticated-orcid":false,"given":"Mireia","family":"Mallandrich-Miret","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"},{"name":"Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7394-3438","authenticated-orcid":false,"given":"Sergio","family":"Mart\u00ednez-Ruiz","sequence":"additional","affiliation":[{"name":"Departament de Bioqu\u00edmica i Fisiologia, Facultat de Farm\u00e0cia i Ci\u00e8ncies de l\u2019Alimentaci\u00f3, Universitat de Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Cordero","sequence":"additional","affiliation":[{"name":"Departament de Bioqu\u00edmica i Fisiologia, Facultat de Farm\u00e0cia i Ci\u00e8ncies de l\u2019Alimentaci\u00f3, Universitat de Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Del Pozo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5363-3125","authenticated-orcid":false,"given":"N\u00faria Bozal-de","family":"Febrer","sequence":"additional","affiliation":[{"name":"Departament de Biologia, Sanitat i Medi Ambient, Facultat de Farm\u00e0cia i Ci\u00e8ncies de l\u2019Alimentaci\u00f3, Universitat de Barcelona (UB), 08028 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14728214.2021.1887138","article-title":"Emerging Topical Drugs for the Treatment of Rosacea","volume":"26","author":"Nasca","year":"2021","journal-title":"Expert. Opin. Emerg. Drugs"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40257-021-00595-7","article-title":"Rosacea: New Concepts in Classification and Treatment","volume":"22","author":"Arents","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Woo, Y.R., Han, Y.J., Kim, H.S., Cho, S.H., and Lee, J.D. (2020). Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut\u2013Brain\u2013Skin Axis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228427"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1067\/mjd.2001.116219","article-title":"Once-Daily Topical Metronidazole Cream Formulations in the Treatment of the Papules and Pustules of Rosacea","volume":"45","author":"Dahl","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: Part I. Introduction, Categorization, Histology, Pathogenesis, and Risk Factors","volume":"72","author":"Two","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard Classification of Rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1542-2011.2011.00156.x","article-title":"Rosacea","volume":"57","author":"Fuller","year":"2012","journal-title":"J. Midwifery Womens Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1099\/jmm.0.048090-0","article-title":"Potential Role of Demodex Mites and Bacteria in the Induction of Rosacea","volume":"61","author":"Jarmuda","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaad.2013.08.006","article-title":"Potential Role of Microorganisms in the Pathogenesis of Rosacea","volume":"69","author":"Holmes","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-020-00460-1","article-title":"Rosacea and the Microbiome: A Systematic Review","volume":"11","author":"Daou","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_11","first-page":"244","article-title":"Rosacea","volume":"99","author":"Barco","year":"2008","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (Engl. Ed.)"},{"key":"ref_12","first-page":"38","article-title":"Rosacea: A Review","volume":"34","author":"Culp","year":"2009","journal-title":"Pharm. Ther."},{"key":"ref_13","first-page":"397","article-title":"Therapeutic Uses of Metronidazole and Its Side Effects: An Update","volume":"23","author":"Ceruelos","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00128071-200001030-00007","article-title":"Topical Metronidazole","volume":"1","author":"McClellan","year":"2000","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000446215","article-title":"Rosacea Management","volume":"2","author":"Abokwidir","year":"2016","journal-title":"Skin. Appendage Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/jocd.14816","article-title":"Rosacea Management: A Comprehensive Review","volume":"21","author":"Sharma","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/j.1875-9114.1981.tb02541.x","article-title":"Topically Administered Clindamycin in the Treatment of Acne Vulgaris and Other Dermatologic Disorders","volume":"1","author":"Rosen","year":"1981","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-4362.1993.tb00974.x","article-title":"Treatment of rosacea: Topical clindamycin versus oral tetracycline","volume":"32","author":"Wilkin","year":"1993","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/10717544.2013.879355","article-title":"Comprehensive Review on Additives of Topical Dosage Forms for Drug Delivery","volume":"22","author":"Garg","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/03639045.2021.1993889","article-title":"Emulgel: An Effective Drug Delivery System","volume":"47","author":"Talat","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.9734\/jpri\/2021\/v33i62B35565","article-title":"Overview of Emulgel as Emergent Topical Delivery: Recent Applications and Advancement","volume":"33","author":"Amgaonkar","year":"2021","journal-title":"J. Pharm. Res. Int."},{"key":"ref_22","unstructured":"(2003). Determination of Minimum Inhibitory Concentrations (MICs) of Antibacterial Agents by Broth Dilution. Clin. Microbiol. Infect., 9, ix\u2013xv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic Susceptibility Testing by a Standardized Single Disk Method","volume":"45","author":"Bauer","year":"1966","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Silva-Abreu, M., Sosa, L., Espinoza, L.C., F\u00e1brega, M.-J., Rodr\u00edguez-Lagunas, M.J., Mallandrich, M., Calpena, A.C., Gardu\u00f1o-Ram\u00edrez, M.L., and Rinc\u00f3n, M. (2023). Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15102403"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12951-021-01092-z","article-title":"Thymol-Loaded PLGA Nanoparticles: An Efficient Approach for Acne Treatment","volume":"19","author":"Folle","year":"2021","journal-title":"J. Nanobiotechnology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09546639109092728","article-title":"Topical Metronidazole in the Treatment of Rosacea","volume":"2","author":"Monk","year":"1991","journal-title":"J. Dermatol. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/03639045.2019.1569026","article-title":"Metronidazole-Loaded Nanostructured Lipid Carriers to Improve Skin Deposition and Retention in the Treatment of Rosacea","volume":"45","author":"Shinde","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejpb.2014.03.019","article-title":"In Vitro\/in Vivo Characterization of Nanoemulsion Formulation of Metronidazole with Improved Skin Targeting and Anti-Rosacea Properties","volume":"88","author":"Yu","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_29","first-page":"1410","article-title":"Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel for Rosacea: Summary of a Placebo-Controlled, Double-Blind Trial","volume":"11","author":"Freeman","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101253","DOI":"10.1016\/j.jddst.2019.101253","article-title":"Harnessing Nanotechnology for Enhanced Topical Delivery of Clindamycin Phosphate","volume":"54","author":"Fatima","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_31","first-page":"641","article-title":"Combined Effect of Anti-Inflammatory Dose Doxycycline (40-Mg Doxycycline, Usp Monohydrate Controlled-Release Capsules) and Metronidazole Topical Gel 1% in the Treatment of Rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"J. Drugs Dermatol."},{"key":"ref_32","first-page":"495","article-title":"Managing Rosacea: A Review of the Use of Metronidazole Alone and in Combination with Oral Antibiotics","volume":"6","author":"Conde","year":"2007","journal-title":"J. Drugs Dermatol."},{"key":"ref_33","first-page":"602","article-title":"Pawar, Nishant V. Pote, Munjaji M. Mule, Rohini B. Chougale, Ms. Wale R.R A Review On: Formulation and Estimation of Topical Emulgel","volume":"2","author":"Chaitanya","year":"2024","journal-title":"Int. J. Pharm. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.13005\/bbra\/2931","article-title":"Emulgel Approach to Formulation Development: A Review","volume":"18","author":"Patel","year":"2021","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5650\/jos.ess23204","article-title":"Medium-Chain Triacylglycerols (MCTs) and Their Fractions in Drug Delivery Systems: A Systematic Review","volume":"73","author":"Zulfakar","year":"2024","journal-title":"J. Oleo Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"Standard Management Options for Rosacea: The 2019 Update by the National Rosacea Society Expert Committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sosa, L., Calpena, A.C., Silva-Abreu, M., Espinoza, L.C., Rinc\u00f3n, M., Bozal, N., Domenech, O., Rodr\u00edguez-Lagunas, M.J., and Clares, B. (2019). Thermoreversible Gel-Loaded Amphotericin B for the Treatment of Dermal and Vaginal Candidiasis. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11070312"},{"key":"ref_38","first-page":"472","article-title":"Complexation, Optimization, Formulation Development and Characterization of Clindamycin Phosphate Gel Using Zinc Acetate Dihydrate","volume":"2","author":"Mishra","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_39","first-page":"340","article-title":"Spectroscopic Characterization of Biofield Treated Metronidazole and Tinidazole","volume":"5","year":"2015","journal-title":"Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kumari, D., Karmakar, V., Sisinthy, S.P., Pandey, M., Jain, N., and Gorain, B. (2024). Nanoemulsion and Nanoemulgel-Based Carriers as Advanced Delivery Tools for the Treatment of Oral Diseases. Drug Deliv. Transl. Res., 1\u201317.","DOI":"10.1007\/s13346-024-01735-2"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Milutinov, J., Krstono\u0161i\u0107, V., \u0106irin, D., and Pavlovi\u0107, N. (2023). Emulgels: Promising Carrier Systems for Food Ingredients and Drugs. Polymers, 15.","DOI":"10.3390\/polym15102302"},{"key":"ref_42","unstructured":"(2025, January 11). Clindamycin: Uses, Interactions, Mechanism of Action|DrugBank Online, Available online: https:\/\/go.drugbank.com\/drugs\/DB01190."},{"key":"ref_43","unstructured":"(2025, January 11). Metronidazole: Uses, Interactions, Mechanism of Action|DrugBank Online, Available online: https:\/\/go.drugbank.com\/drugs\/DB00916."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Caparica, R., J\u00falio, A., Fernandes, F., Ara\u00fajo, M.E.M., Costa, J.G., and Santos de Almeida, T. (2021). Upgrading the Topical Delivery of Poorly Soluble Drugs Using Ionic Liquids as a Versatile Tool. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094338"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpb.2018.05.024","article-title":"Use of Biorelevant Dissolution and PBPK Modeling to Predict Oral Drug Absorption","volume":"129","author":"Kaur","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Gu, B., and Burgess, D.J. (2014). Polymeric Materials in Drug Delivery. Natural and Synthetic Biomedical Polymers, Elsevier.","DOI":"10.1016\/B978-0-12-396983-5.00021-1"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2010.06.008","article-title":"Drug Release from Hydroethanolic Gels. Effect of Drug\u2019s Lipophilicity (Log P), Polymer\u2013Drug Interactions and Solvent Lipophilicity","volume":"396","author":"Sawant","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1208\/s12249-020-01799-6","article-title":"A New Approach to Ex Vivo Permeation Studies in In-Situ Film-Forming Systems","volume":"21","author":"Ferreira","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"104990","DOI":"10.1016\/j.tiv.2020.104990","article-title":"Partition Coefficient and Diffusion Coefficient Determinations of 50 Compounds in Human Intact Skin, Isolated Skin Layers and Isolated Stratum Corneum Lipids","volume":"69","author":"Ellison","year":"2020","journal-title":"Toxicology Vitr."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Szunerits, S., and Boukherroub, R. (2018). Heat: A Highly Efficient Skin Enhancer for Transdermal Drug Delivery. Front. Bioeng. Biotechnol., 6.","DOI":"10.3389\/fbioe.2018.00015"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02849891","article-title":"Percutaneous Absorption Kinetics of Topical Metronidazole Formulations in Vitro in the Human Cadaver Skin Model","volume":"24","author":"Elewski","year":"2007","journal-title":"Adv. Ther."},{"key":"ref_52","unstructured":"(2024, October 26). CIMA: CLINDAMICINA NORMON 300 Mg\/2 Ml SOLUCION INYECTABLE EFG. Available online: https:\/\/cima.aemps.es\/cima\/publico\/detalle.html?nregistro=63667."},{"key":"ref_53","unstructured":"(2024, October 26). CIMA: METRONIDAZOL NORMON 250 Mg COMPRIMIDOS EFG. Available online: https:\/\/cima.aemps.es\/cima\/publico\/detalle.html?nregistro=62223."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ellis, S.R., Nguyen, M., Vaughn, A.R., Notay, M., Burney, W.A., Sandhu, S., and Sivamani, R.K. (2019). The Skin and Gut Microbiome and Its Role in Common Dermatologic Conditions. Microorganisms, 7.","DOI":"10.3390\/microorganisms7110550"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.det.2010.03.015","article-title":"Innovative Use of Topical Metronidazole","volume":"28","author":"Zip","year":"2010","journal-title":"Dermatol. Clin."},{"key":"ref_56","first-page":"211","article-title":"3D Culture Of HaCaT Keratinocyte Cell Line as an in vitro Toxicity Model","volume":"23","author":"Hayal","year":"2022","journal-title":"Trak. Univ. J. Nat. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nano.2019.03.017","article-title":"Nanoemulsion Strategy of Pioglitazone for the Treatment of Skin Inflammatory Diseases","volume":"19","author":"Espinoza","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Zhang, H., and Dhalla, N.S. (2024). The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021082"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e2024267","DOI":"10.5826\/dpc.1404a267","article-title":"Serum Biomarkers IL-6 and HIF-1\u03b1 in Rosacea: Assessing Their Significance in Disease Pathogenesis and Telangiectasia Formation","volume":"14","author":"Cemil","year":"2024","journal-title":"Dermatol. Pract. Concept."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Yang, F., Wang, L., Song, D., Zhang, L., Wang, X., Du, D., and Jiang, X. (2024). Signaling Pathways and Targeted Therapy for Rosacea. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1367994"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kany, S., Vollrath, J.T., and Relja, B. (2019). Cytokines in Inflammatory Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236008"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105971","DOI":"10.1016\/j.phrs.2021.105971","article-title":"Exploring Metformin as a Candidate Drug for Rosacea through Network Pharmacology and Experimental Validation","volume":"174","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"173817","DOI":"10.1016\/j.ejphar.2020.173817","article-title":"IL-6 Promotes Nuclear Translocation of HIF-1\u03b1 to Aggravate Chemoresistance of Ovarian Cancer Cells","volume":"894","author":"Xu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40744-024-00699-6","article-title":"Over Activation of IL-6\/STAT3 Signaling Pathway in Juvenile Dermatomyositis","volume":"11","author":"Zheng","year":"2024","journal-title":"Rheumatol. Ther."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/2\/168\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:36:55Z","timestamp":1759919815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/2\/168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":64,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["pharmaceutics17020168"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17020168","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]}}}